100.00% -0.661

Acorda Therapeutics Inc (ACOR)

Acorda Therapeutics Inc (ACOR) 最新ニュース

Acorda Therapeutics Inc (ACOR)

Acorda Therapeutics Inc (ACOR) 最新ニュース

Acorda: Q1 Earnings Snapshot - Milford Mirror

Acorda Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 - Marketscreener.com

Acorda Therapeutics (NASDAQ:ACOR) Earns Buy Rating from Analysts at StockNews.com - Defense World

Acorda (ACOR) Q4 Earnings and Revenues Surpass Estimates - Yahoo Canada Shine On

Progressive Supranuclear Palsy Therapeutics Market Size and Shar - NEWS CHANNEL NEBRASKA

Acorda Therapeutics (ACOR) Reports Q2 Loss, Tops Revenue Estimates - Yahoo New Zealand News

Acorda Therapeutics (ACOR) Outpaces Stock Market Gains: What You Should Know - Yahoo Movies Canada

Acorda Therapeutics Strikes Creditor Deal On Ch. 11 Loan - Law360

Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket

Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket - Markets Insider

Why Ascent Solar Technologies Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

UPDATED: Acorda inks $185M asset sale to Merz, files for bankruptcy after years of disappointing sales - FiercePharma

Acorda Pharmaceuticals in Rockland County NY to shut; 97 jobs lost - The Journal News

Acorda seeks buyer as neurological drug sales fall - Westfair Online

Pearl River biotech firm up for sale after filing for bankruptcy - Crain's New York Business

Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Why Cal-Maine Foods Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

Acorda Joins Growing Group of Biotechs Filing for Bankruptcy, Divests Assets to Merz - BioSpace

Nasdaq Down Over 1%; VivoPower International Shares Spike Higher

Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Crude Oil Surges Over 1%; US Factory Orders Increase In February

Dow Dips Over 400 Points; Paychex Posts Downbeat Sales

Why VirTra Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket

Acorda Therapeutics' Strategic Bankruptcy and Asset Sale Plan - TipRanks.com - TipRanks

Nasdaq Down Over 1%; VivoPower International Shares Spike Higher - Gritstone Bio (NASDAQ:GRTS) - Benzinga

Acorda Cancels Q4 and Year End 2023 Earnings Conference Call Scheduled for April 1, 2024 - Business Wire

Acorda Says Tribunal Ignored Patent Law In MS Drug Feud - Law360

Health Check: How Prudently Does Acorda Therapeutics (NASDAQ:ACOR) Use Debt? - Simply Wall St

Easy-to-use inhaled levodopa system readying request for US... - Parkinson's News Today

Acorda taking over global sales of Ampyra and Fampyra for MS - Multiple Sclerosis News Today

Biogen Bows Out of Acorda Pact on MS Med; Focus Turns to New Growth Drivers - MedCity News

ORGO: 3 Biotech Stocks to Keep an Eye on in 2024 - StockNews.com

ACOR: Moderna (MRNA) and Acorda Therapeutics (ACOR): Buy, Hold, or Sell in 2024? - StockNews.com

Acorda Therapeutics Reports Third Quarter 2023 Financial Results - Business Wire

6 Latin American countries asked to OK Inbrija for Parkinson's off... - Parkinson's News Today

Acorda Therapeutics Announces Biopas Laboratories Submission to Regulatory Agencies in Six Latin American ... - Yahoo Finance

SGIOY: 3 Biotech Stocks to Buy under $20 - StockNews.com

Acorda Therapeutics (ACOR): A Comprehensive Analysis of Its Market Value - Yahoo Finance

Acorda launches new campaign, website for Inbrija for Parkinson's... - Parkinson's News Today

Acorda Therapeutics Announces Launch of New INBRIJA® Campaign: "For The Fighters™" - Yahoo Finance

Acorda, Chance sign deals to commercialise INBRIJA in China - Pharmaceutical Technology

Acorda Therapeutics and Chance Pharmaceuticals Announce Agreement to Commercialize INBRIJA® in China - Business Wire

Inbrija, inhaled levodopa for Parkinson's off periods, arrives in... - Parkinson's News Today

Who are the leading innovators in cancer monoclonal antibody therapy for the pharmaceutical industry? - Pharmaceutical Technology

Acorda Says It's Owed $65M More In MS Drug Fight - Law360

Why Acorda Therapeutics Shares Are Trading Higher By 55%; Here Are 28 Stocks Moving Premarket By Benzinga - Investing.com UK

Acorda Therapeutics Announces $16.5M Award and Royalty/Supply Relief in AMPYRA® Arbitration Case - Business Wire

Acorda Therapeutics Chief Operating Officer Lauren Sabella to Retire - citybiz

ACOR stock surges 50% on Parkinson's disease drug launch (NASDAQ:ACOR) - Seeking Alpha

ACORに似た銘柄